Oxadiazole derivatives as DGAT inhibitors

Details for Australian Patent Application No. 2008290327 (hide)

Owner AstraZeneca AB

Inventors Butlin, Roger John; Gill, Adrian Liam; Plowright, Alleyn Thomas; Birch, Alan Martin; Waring, Michael James; Groombridge, Samuel David

Agent Davies Collison Cave

Pub. Number AU-A-2008290327

PCT Pub. Number WO2009/024821

Priority 60/990,970 29.11.07 US; 60/956,490 17.08.07 US

Filing date 15 August 2008

Wipo publication date 26 February 2009

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/024821 Priority application(s): WO2009/024821

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008290328-Diagnostic method and kit

2008290325-Cannabinoid receptor ligands